Nipro Injects Innovation into Pre-filled Syringes and Targets US Expansion

摘要

Medical devices, pharmaceuticals and glass pharmaceutical packaging products are the forte of the Nipro Corporation, and as such is well positioned to benefit from the rising global prefilled syringes market, which accounted for $3.9 billion in 2014 and is expected to grow with a CAGR of 12.9% during 2015-2020. Yoshihiko Sano, President of Nipro Corporation, explains how it is on track to hit its ambitious growth targets for 2020, its corporate culture of innovation, and its commitment to improve the working lives of medical staff and the healthy life expectations of people worldwide.